Heme Flashcards

1
Q

What are the components of FLIPI-2? PFS?

A

Beta MASH
Beta-2 microglobulin
Marrow +
Size >6cm
Hgb <12
Age > 60yra
5yr PFS
Low (0) 80%
Int (1-2) 50%
High (3-5) 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

R-IPI for DLBCL and 5yr OS estimates?

A

APLES
Age
PS 2+
LDH >nml
2+ Extranodal sites
Stage III-IV

0=95%
2-3=80%
4-5=60%
6=30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Deauville score?

A

1) No uptake
2) <+mediastinum
3) mediastinum<uptake<=liver
4) Uptake moderately > liver
5) Uptake markedly > liver or presence of new lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What IHC markers for HL?

A

CD 15 and 30+, 20 and 45 neg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classic HL IPS score?

A

SAM HALL
Stage IV
Age >=45
Male
Hgb <10.5
Albumin
Lymphocytopenia
Leukocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When would you give ISRT for III-IV classic HL?

A

Initially bulky or residual after all cycles of systemic therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Breast screening for pts tx with RT for lymphoma?

A

8yrs after RT or age 40 whatever comes 1st.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Workup for Hodgkins Lymphoma?

A

B symptoms, CBC, CMP, ESR, LDH, HIV, PET, pregnancy test, fertility counseling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NCCN criteria for unfavorable HL?

A

bulky >10cm, B symptoms, ESR >50, >3 sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Favorable HL pathway if PET2 1-3?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Favorable HL pathway if PET2 with DV 4-5.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Unfavorable HL pathway?

A

Can also do NIvo-AVDx4 with ISRT 30Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe ISRT in words?

A

ISRT targets the originally involved lymph nodes, accounting for inaccuracies in pre-chemotherapy imaging and anatomical changes after chemotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

FLIPI-2?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do you eval in pt with gastric MALT?

A

HepB/C, H. pylori (IHC if neg breath or stool), look for t(11:18)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment for testicular DLBCL?

A

MRI brain/LP
Radical orchietomy–>RCHOPx6 +IT MTXx4–>RT to contra testicle 30/15, frog leg, direct ant electron, bolus, tape penis.

17
Q

What is R-CHOP?

A

R = Rituximab
C = Cyclophosphamide
H = Doxorubicin Hydrochloride (Hydroxydaunomycin)
O = Vincristine Sulfate (Oncovin)
P = Prednisone

18
Q

How do you tx PMBCL?

A

R = Rituximab
E = Etoposide Phosphate
P = Prednisone
O = Vincristine Sulfate (Oncovin)
C = Cyclophosphamide
H = Doxorubicin Hydrochloride (Hydroxydaunorubicin)

DA-R-EPOCH x 6 🡪 D1-3: observe

If D4-5 biopsy and then tx as refractory or give ISRT 30Gy+ boost PET avid to

19
Q

FLIPI-2? 5yr PFS?

A

Beta2 Mg >nml
Marrow+
Age>60yrs
Size >6cm
Hbg <12

Low (0): 80%
Int (1-2): 50%
High (3-5): 20%

20
Q

What infradiaphragmatic sites are together for GHSG staging?

A

Paraortic and Mesenteric

21
Q

Follicular Lymphoma grading?Transformation to DLBCL? Percent risk of +BM? Percent presenting at each stage?

A

GRADING: # centroblasts / cleaved cells per HPF
1: 0-5
2: 6-15
3: >15 A: centrocytes present, B: lack centrocytes

STAGING
I: 10%
II: 20%
III/IV: 70%

15% transform and 50% BM+.

22
Q

Criteria for MM? What systemic therapy?

A

Clonal bone marrow plasma cells >10% or bony/extramedullary plasmacytoma and:
CRAB: hypercalemia, renal insufficieny, Anemia, Bone lesions
or Involved:uninvolved serum free light chains >100, >1 focal lesion on MRI studies.

Daratumumab/lenalidomide

23
Q

TSEBT script?

A

12Gy in 8 fractions 4 days a week with electrons
Goal to deliver 12Gy to skin surface using extended SSD using acrylic sheet to scatter dose
2 beams gantry pointing above and below pt +/-20 degrees
Treated using stanford technique; 1 fraction over 2 days using 3 body positions per day.
Shadowed areas supplemented (sclap, axilla, pannus, perineum etc).

Tox: Desquamation, hair loss, lymphedema, nail loss, loss of perspiration, secondary cancer, parotitis.

24
Q

Mycosis Fungoides T staging? Workup?

A

T1: <10% BSA
T2: >=10% BSA
T3: one or tumors >=1cm
T4: >80% BSA

CBC w diff, CMP, LDH, flow cytometry with Cezary screen, PET if T3.

25
How do you treat primary cutaneous B-cell lymphoma or primary cuteanous follicle center lymphoma?
24Gy in 12 fractions, lower doses (4Gy) can be used.
26